The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Zenyaku Kogyo receives Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat chronic ITP in children: Tokyo Saturday, November 23, 2024, 10:00 Hrs [IST] Zenyaku Ko ...

Rabbit Monoclonal Primary Antibody companion diagnostic) BTC and is the largest phase 2b clinical trial to date specifically for this patient population. The trial achieved its primary endpoint of ...

According to Alnylam’s Tim Mooney, mivelsiran’s endurance is due to stabilizing tweaks the scientists made to the siRNA ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

Some hospitals in the U.S. are seeing an increase in RSV and higher levels of "walking pneumonia" among young children despite overall respiratory illness activity remaining low nationally.

As bispecific antibodies gain prominence for their revolutionary therapeutic ... In the Phase 3 RESILIENT study, TNX-102 SL met the pre-specified primary endpoint of significantly reducing daily pain ...

Honesty is the best policy, says Myricx's CEO, who used authentic relationships with investors to help the biotech win major funding after a pivot.The ...

A majority of Americans are not planning to get a COVID-19 booster vaccine this season, according to a survey.The Pew ...

The primary end point is overall survival. Secondary endpoints include event-free survival, response rates including CR, CR+CRh, and rates of MRD negativity. Cusatuzumab is a first-in-class ...

In clinical trials, London School of Hygiene and Tropical Medicine has demonstrated that mosquito bites can deliver malaria vaccine safely.